
Jae Park, MD, Memorial Sloan Kettering Cancer Center
Advertisement
Articles by Jae Park, MD, Memorial Sloan Kettering Cancer Center

Advertisement
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Atezolizumab Plus Chemo for Stage III dMMR Colon Cancer
2
FDA Approves Tucatinib Plus Trastuzumab/Pertuzumab as First-Line Maintenance in Advanced HER2+ Breast Cancer
3
VIR-5500 Receives FDA Fast Track Designation in mCRPC
4
September Roundup of FDA Approvals in Oncology: 8 Decisions to Know
5
